Recursion Pharmaceuticals Inc Clas (RXRX)
Capital Expenditure
-$3.78M
TTM · Period ending: · USD
RXRX Capital Expenditure
Latest reported-$3.78Mperiod ending
Latest reported-$3.78Mperiod ending
RXRX TTM CapEx (-$6.74M → -$3.78M)
TTM CapEx
High-resolution chart · PNG
RXRX capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -3,784,000 | |
| -4,975,000 | |
| -6,469,000 | |
| -6,873,000 | |
| -11,192,000 | |
| -12,224,000 | |
| -17,045,000 | |
| -17,814,000 | |
| -14,079,000 | |
| -13,865,000 | |
| -12,552,000 | |
| -18,114,000 | |
| -25,850,000 | |
| -38,357,000 | |
| -37,359,000 | |
| -33,844,000 | |
| -34,987,000 | |
| -24,724,000 | |
| -39,798,000 | |
| -39,925,000 | |
| -31,045,000 | |
| -25,467,000 | |
| -6,735,000 |